Portrait of Edward P. Gerstenfeld
ucsf logo

Edward P. Gerstenfeld, MD, MS

Electrophysiology • CardiologyChief, Cardiac Electrophysiology and Arrhythmia
Cardiology Parnassus
415-353-2873
Portrait of Edward P. Gerstenfeld
Portrait of Edward P. Gerstenfeld
ucsf logo

Edward P. Gerstenfeld, MD, MS

Electrophysiology • CardiologyChief, Cardiac Electrophysiology and Arrhythmia
Cardiology Parnassus
415-353-2873

On this page

About me

Dr. Edward P. Gerstenfeld is chief of the UCSF Cardiac Electrophysiology and Arrhythmia Service. His expertise includes treating arrhythmias, or irregular heartbeats, with catheter ablation. Specific techniques, such as endocardial and epicardial ablation, may be used for atrial fibrillation, supraventricular tachycardia or ventricular tachycardia.

Gerstenfeld also specializes in treating patients with inherited arrhythmia syndromes such as arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy, Brugada syndrome, long QT syndrome and adult congenital heart disease. Treatments include implantation of pacemakers, defibrillators and cardiac resynchronization devices.

In his research, Gerstenfeld studies the mechanisms of arrhythmia, new technologies for mapping and ablation of arrhythmias, biomedical signal processing and electrocardiography. He is the primary investigator for several clinical trials.

Gerstenfeld earned a medical degree at Northwestern University Feinberg School of Medicine and a master of science degree in biomedical engineering at Northwestern University. He completed a residency at Beth Israel Deaconess Medical Center, a cardiology fellowship at the University of Massachusetts, a research fellowship at UCSF and an electrophysiology fellowship at the University of Pennsylvania.

Gerstenfeld is a fellow of the American College of Cardiology and a member of the Heart Rhythm Society and American Heart Association. He has published numerous manuscripts and book chapters, and he often lectures on mapping and treating arrhythmias. He is associate editor of the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology.

Education & training

Board certification

  • Clinical Cardiac Electrophysiology, American Board of Internal Medicine

Fellowship

  • Cardiac Electrophysiology, Hospital of the University of Pennsylvania
  • Cardiology, University of Massachusetts Med Ctr Medical School

Residency

  • Internal Medicine, Beth Israel Deaconess Medical Center - Int Med GME

Internship

  • Internal Medicine, Beth Israel Deaconess Medical Center - Int Med GME

Degree

  • MD, Northwestern University Feinberg School of Medicine

Locations

    My work

    New arrhythmia treatment allows for faster, safer recovery

    An innovative therapy being tested at UCSF uses targeted electrical pulses to treat atrial fibrillation (A-fib). Dr. Gerstenfeld explains the advantages.

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    291 ratings
    About provider reviews

    Showing 1-6 of 57 reviews

    Sort by
    • 5 out of 5 Stars
      December 22, 2025

      We had a cordial and informative conversation.

    • 5 out of 5 Stars
      December 21, 2025

      Dr. Gerstenfeld was attentive, warm, informed regarding my chart and shared his expertise while listening to my questions/concerns.

    • 5 out of 5 Stars
      December 18, 2025

      Dr. Gerstenfeld and Dr. Feseha were both excellent.

    • 4.6 out of 5 Stars
      December 4, 2025

      Very professional n attentive

    • 5 out of 5 Stars
      November 12, 2025

      Dr. G was very through.

    • 5 out of 5 Stars
      October 20, 2025

      This cardiologist is excellent!

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.